Dosage forms having an inner core and an outer shell
OwnerHarry S Sowden, Frank J Bunick +3inventors
InventorsHarry S Sowden, Frank J Bunick, John Burke, Der-Yang Lee, Martin Thomas
Life of this patent
Estimating the term…
Abstract
An immediate release tablet is provided. The tablet comprises at least 60 weight % of an active ingredient and powdered wax having a melting point greater than about 90° C. The tablet may advantageously be produced by direct compression. Although the wax is hydrophobic, the tablet has excellent disintegration.
Claims20
An immediate release tablet comprising at least 60 weight % of an active ingredient and a powdered wax having an melting point greater than about 90° C., said tablet meeting the USP dissolution specifications for immediate release tablets containing said active ingredient.
An immediate release tablet comprising at least 60 weight percent of an active ingredient and a powdered wax selected from the group consisting of shellac wax, paraffin-type waxes, polyethylene glycol, and mixtures thereof;
- wherein said tablet is prepared by direct compression.
An immediate release tablet comprising at least 60 weight percent of an active ingredient and a powdered wax selected from the group consisting of shellac wax, paraffin-type waxes, polyethylene glycol, and mixtures thereof;
- wherein said tablet is substantially free of water-soluble, non-saccharide polymeric binders.
An immediate release tablet comprising at least 60 weight percent of an active ingredient and a powdered wax selected from the group consisting of shellac wax, paraffin-type waxes, polyethylene glycol, and mixtures thereof, wherein said tablet is substantially free of hydrated polymers.
Dependencies are inferred from the claim text.